期刊
JOURNAL OF NERVOUS AND MENTAL DISEASE
卷 203, 期 5, 页码 310-318出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/NMD.0000000000000284
关键词
Early intervention; psychosis; prevention; service reform
资金
- Colonial Foundation
- National Health and Medical Research Council of Australia
- NARSAD
- Stanley Foundation
- Australian government
- Victorian government
- Janssen-Cilag
- Astra Zeneca
- Bristol-Meyer-Squibb
- Eli Lilly
- Pfizer
Early intervention for potentially serious disorder is a fundamental feature of healthcare across the spectrum of physical illness. It has been a major factor in the reductions in morbidity and mortality that have been achieved in some of the non-communicable diseases, notably cancer and cardiovascular disease. Over the past two decades, an international collaborative effort has been mounted to build the evidence and the capacity for early intervention in the psychotic disorders, notably schizophrenia, where for so long deep pessimism had reigned. The origins and rapid development of early intervention in psychosis are described from a personal and Australian perspective. This uniquely evidence-informed, evidence-building and cost-effective reform provides a blueprint and launch pad to radically change the wider landscape of mental health care and dissolve many of the barriers that have constrained progress for so long.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据